Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
1.600
-0.045 (-2.74%)
At close: Oct 2, 2026, 4:00 PM EDT
1.610
+0.010 (0.63%)
After-hours: Oct 2, 2026, 4:29 PM EDT
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $584.16 million as of October 2, 2026. Its market cap has decreased by -55.74% in one year.
Market Cap
584.16M
Enterprise Value
595.73M
1-Year Change
-55.74%
Ranking
Category
Stock Price
$1.60
ChartMarket Cap Chart
Since the IPO on November 4, 2021, Evotec SE's market cap has decreased from $9.19B to $584.16M, a decrease of -93.64%. That is a compound annual growth rate of -42.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 584.16M | -48.61% |
| Dec 30, 2025 | 1.14B | -24.59% |
| Dec 30, 2024 | 1.51B | -63.78% |
| Dec 29, 2023 | 4.16B | 44.42% |
| Dec 30, 2022 | 2.88B | -65.81% |
| Dec 30, 2021 | 8.43B | -8.26% |
| Nov 4, 2021 | 9.19B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pacira BioSciences | 1.00B |
| Collegium Pharmaceutical | 717.85M |
| Ironwood Pharmaceuticals | 601.47M |
| Aquestive Therapeutics | 571.08M |
| Glass House Brands | 517.39M |
| Tilray Brands | 494.54M |
| Alpha Teknova | 482.66M |
| Kamada | 475.28M |